Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

New ESC Guidelines Support Recent Medtronic Innovations for Patients with Atrial Fibrillation

DUBLIN - September 12, 2016 -   Two Medtronic plc (NYSE: MDT) innovations were acknowledged in updated guidelines published by the European Society of Cardiology (ESC): cryoballoon ablation for patients with diagnosed atrial fibrillation (AF), and long-term cardiac monitoring for survivors of stroke who do not have an established diagnosis of AF.

New zip skin closures save time in cath lab, reduce tissue damage

A new noninvasive skin closure device is more efficient and effective than other models when used during heart surgery, according to findings in a new study.

Thumbnail

Researchers launch study to evaluate risks, benefits of ECG screening in high school athletes

Researchers in Texas are launching a pilot study examining whether electrocardiograms (ECGs) are useful in identifying high school athletes who are at risk of sudden cardiac death.

Express Scripts Launches Diabetes Care Value Program℠, Guaranteeing More Affordable, Higher-Quality Diabetes Care

ST. LOUIS, Aug. 31, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced the launch of its Diabetes Care Value Program℠, the industry's most comprehensive approach to improve pharmacy care while controlling plan costs for people with diabetes.

Experts Discuss Non-Responders to CRT and AF Ablation at ESC Scientific Symposium

(PresseBox) EPIC Alliance experts at the European Society of Cardiology (ESC) congress presented original research and real-world clinical evidence on non-responders to cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) ablation today.

BIOTRONIK Home Monitoring Proven to Reduce Risk of All-Cause Mortality for All Types of ICD Patients

(PresseBox) During a scientific talk at the 2016 European Society of Cardiology (ESC) Congress, Dr. Gerhard Hindricks, Leipzig Heart Center, Germany, presented results of a meta-study showing that BIOTRONIK Home Monitoring® is associated with a 38 percent reduced risk for all-cause mortality after one year in all ICD patients. 

Thumbnail

CMR- and MPS-guided care may reduce invasive angiography in patients with suspected coronary heart disease

A randomized trial found that patients with suspected coronary heart disease who underwent cardiovascular magnetic resonance (CMR)–guided care had a significantly lower probability of unnecessary angiography within 12 months compared with patients who received National Institute for Health and Care Excellence (NICE) guidelines–directed care. The difference was not statistically different between CMR-guided care and myocardial perfusion scintigraphy (MPS)–guided care.

Medtronic Technologies Improve Delivery of Cardiac Resynchronization Therapy

DUBLIN and ROME - Aug. 29, 2016 - Medtronic plc (NYSE:MDT) today announced results from the Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee) study. The study showed that the Medtronic-exclusive device-based EffectivCRT(TM) during AF algorithm improves therapy delivery in heart failure patients with atrial fibrillation (AF). The results were presented at the 2016 European Society of Cardiology (ESC) Congress in Rome.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.